Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Declines By 80.1%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a significant drop in short interest in October. As of October 31st, there was short interest totalling 2,800 shares, a drop of 80.1% from the October 15th total of 14,100 shares. Based on an average trading volume of 91,400 shares, the days-to-cover ratio is currently 0.0 days.

BriaCell Therapeutics Stock Down 9.2 %

BCTXW traded down $0.03 during trading hours on Tuesday, reaching $0.27. The company’s stock had a trading volume of 94,722 shares, compared to its average volume of 72,665. The company’s 50-day moving average is $0.29 and its 200-day moving average is $0.35. BriaCell Therapeutics has a 52 week low of $0.11 and a 52 week high of $2.60.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.